Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study. Am J Physiol Heart Circ Physiol 296: H1940-H1948, 2009. First published April 3, 2009; doi: 10.1152/ajpheart.01177.2008.-Serotonergic drugs, such as pergolide, have been associated with the development of cardiac valvular myxoid thickening and regurgitation in humans and more recently in rats. These effects are potentially mediated by the 5-hydroxytryptamine (5-HT)(2B) receptor (5-HT2BR). Therefore, we sought to determine whether cyproheptadine, a 5-HT2BR antagonist, might prevent toxic valvulopathy in an animal model of pergolide-induced valvular heart disease. For this purpose, 50 male Wistar rats received daily intraperitoneal injections of pergolide (0.5 mg/kg, n = 14), pergolide (0.5 mg/kg) combined with cyproheptadine (10 mg/kg, n = 12), cyproheptadine (10 mg/kg, n = 12), or no injections (control, n = 12) for 20 wk. Echocardiography was performed blindly at baseline and at 10 and 20 wk followed by pathology. At baseline, no differences between groups were found with echocardiography. At 20 wk, aortic regurgitation was present in all pergolide-treated animals, whereas it was less frequently observed in the other groups (P <0.0001). For the other valves, this difference was less pronounced. On histopathology, not only aortic but also mitral valves were thicker, myxoid, and exhibited more 5-HT2BR-positive cells in pergolidetreated animals compared with the other groups. Moreover, regurgitant aortic and mitral valves were thicker than nonregurgitant aortic and mitral valves. In conclusion, we found that cyproheptadine prevented pergolide-induced valvulopathy in rats, which was associated with a reduced number of 5-HT2BR-positive valvular cells. This may have important clinical implications for the prevention of serotonergic drug-induced valvular heart disease.
Original languageEnglish
Pages (from-to)1940-1948
Number of pages9
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume296
Issue number6
Publication statusPublished - 3 Apr 2009

Keywords

  • drugs
  • echocardiography
  • pathology
  • valves

Fingerprint

Dive into the research topics of 'Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study'. Together they form a unique fingerprint.

Cite this